Article Text

Download PDFPDF
Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis.
  1. G S Alarcón,
  2. O Castañeda,
  3. M G Nair,
  4. M Ferrándiz,
  5. W J Koopman,
  6. C L Krumdieck
  1. Department of Medicine, University of Alabama, Birmingham.


    A 15 week double blind controlled trial of methotrexate and 10-deazaaminopterin for the treatment of rheumatoid arthritis (RA) was performed in 26 patients. Significant improvement in all measured clinical parameters was observed in the two patient groups. The drugs were well tolerated; only one patient (10-deazaaminopterin) withdrew from the study because of side effects. It is concluded that, in the context of this relatively short clinical trial, 10-deazaaminopterin is at least as beneficial as methotrexate in the treatment of RA.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.